🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Wonderful few days in beautiful Stockholm catching up with friends and discussing new data and key challenges in upper gastrointestinal oncology at the Nordic meeting. Thank you to Magnus Nilsson Fredrik Klevebro Bo Jan Noordman for hosting!🇸🇪☺️

CLDN18 Expression and Isoform Distribution mainly in GI cancers. Trend of reduced overall CLDN18 expression after chemo with decrease CLDN18.2/18.1 proportion. Need similar analysis of isoform switch after chemo+Zolbe OncoAlert onlinelibrary.wiley.com/doi/10.1111/ca…

Congrats David O Reilly on the PLAN trial: plasma-first liquid biopsy (LB) v tissue (TB) for NSCLC in🇮🇪 EJCANCER: - 138pts - 3wk⬇️in time to genomic result,LB>TB - 90% concordance - LB half the cost (micro-cost analysis) OncoAlert Beaumont RCSI Cancer Centre #LCSM ejcancer.com/article/S0959-…

📣 have you been diagnosed with cancer, and are experiencing menopausal symptoms as a result of your treatment? we’re looking to hear from you! please consider completing our survey if you are eligible, it will only take 15 minutes of your time! tinyurl.com/menocancersurv…

Original Article: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer (KEYNOTE-689 phase 3 trial) nej.md/45X0Nuc Editorial: Harnessing Immunotherapy in Curative-Intent Treatment of Head and Neck Cancer nej.md/4e6T0fr #Oncology

Great to see such progress, but we have a lot of work to do for patients with lung, oesphageal, liver and pancreatic cancers. Reflects the absolute importance of #ClinicalTrial in improving outcomes CancerTrialsIreland 🌈 Trinity St James's Cancer Institute Irish Research Radiation Oncology Group Irish Cancer Society

Just published in The Lancet! We show that the capsule sponge improves Barrett's surveillance, helping prioritize high-risk patients for endoscopy & offering a more efficient, patient-friendly approach for low-risk individuals. thelancet.com/journals/lance… #GITwitter #Earlydetection

Congratulations- look forward to supporting your work

Big News!📰 Trinity St James's Cancer Institute is now officially Ireland’s first Comprehensive Cancer Centre,Organisation of European Cancer Institutes🧬 This means better care, cutting-edge treatment & more support for patients. A very proud moment for Irish Healthcare! 🏥

Preservation of the proximal stomach important not just for reservoir function but also in minimising the adverse enteroendocrine effect of gastrectomy on skeletal muscle mass and bone health via ghrelin and IGF1 signaling - nice study researchgate.net/publication/39…

A phenomenal achievement and testament to the work of so many, the brilliant Trinity St James's Cancer Institute team led by M John Kennedy Maeve Lowery and wider Trinity College Dublin St James's Hospital community who came together around this shared mission to drive improved care for our patients Irish Cancer Society

The Trinity St James's Cancer Institute has become the first & only Comprehensive #Cancer Centre in Ireland, accredited by Organisation of European Cancer Institutes. This prestigious achievement is the culmination of nearly a decade of hard work & close collaboration between Trinity College Dublin & St James's Hospital tcd.ie/news_events/to…

Be sure to bring this event to the attention of your patients and their families. A fantastic initiative from Trinity St James's Cancer Institute supported by Irish Cancer Society.

A proud achievement for the TSJCI Young Onset Cancer Programme Trinity St James's Cancer Institute St James's Hospital Trinity College Dublin who is now an associate member of Digestive Cancers Europe

dailyreporter.esmo.org/esmo-gastroint…

SANO trial: innovations, risks, and unanswered questions - felt very strongly along with several UGI colleagues we must highlight the important limitations of the SANO trial and thus counsel our patients appropriately regarding these results! ⁦ thelancet.com/journals/lanon…

The capsule sponge test, developed by Rebecca Fitzgerald Lab, will be offered in certain high-street pharmacies as part of an NHS trial to prevent oesophageal cancer.

Isle of Skye c.o Beauty of Scotland 🏴󠁧󠁢󠁳󠁣󠁴󠁿

Today’s Young Onset event begins with an opening address on Young Onset cancers by Professor Maeve Lowery GI medical oncologist and Co director of the Young onset cancer programme at Trinity St James's Cancer Institute Irish Cancer Society

Thank you to our panel GI medical oncologist Emily Harrold , Colorectal surgeon Michael Kelly , and UGI surgeon Jessie Elliot, discussing GI Young Onset cancer and support of shared decision making Trinity St James's Cancer Institute St James's Hospital